Publications by authors named "Longbing Mao"

Claim this Profile
P
PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway.
Yanyan Zhang, Longbing Mao, Alan Jiang, Jingchao Liu, Yongan Lu

Exp Eye Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.
Alan Jiang, Weiqi Wu, Caixia Xu, Longbing Mao, Sha Ao

Invest Ophthalmol Vis Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma.
Xing Liu, JianZhong He, Longbing Mao, Yanyan Zhang, WenWen Cui

Exp Eye Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Yanyan Zhang, Sujuan Duan, Alan Jang, Longbing Mao, Xing Liu

Exp Eye Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitor, AR-42, exerts antitumor effects by inducing apoptosis and cell cycle arrest in Y79 cells.
Sujuan Duan, Xiaona Gong, Xing Liu, Wenwen Cui, Kaddie Chen, Longbing Mao

J Cell Physiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis